Neutral impactResults
Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 crore
Economic Times 1 hr ago·3 Nov 2026, 1:13 pm
Emcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substantial growth. Revenue surged from Rs 2,269.82 crore to Rs 2,820.47 crore during this period, with international operations increasing by 34 per cent. Additionally, domestic revenue witnessed an 11.1 per cent rise, as company leaders expressed confidence in sustaining this positive trend through the latter half of FY27.
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Emcure Pharmaceuticals L (EMCURE).
- Category: Results.
Why it matters
A routine update for Emcure Pharmaceuticals L. Use the price and stock snapshot to gauge how the market is responding.
